Td Asset Management Inc Pardes Biosciences, Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	SELL	$2.14 - $3.7 $32,324 - $55,888	-15,105 Reduced 36.31%	26,500 $53,000
Q2 2022 Aug 04, 2022	SELL	$2.84 - $8.57 $104,796 - $316,233	-36,900 Reduced 47.0%	41,605 $128,000
Q1 2022 May 10, 2022	SELL	$5.64 - $15.64 $22,520 - $62,450	-3,993 Reduced 4.84%	78,505 $567,000
Q4 2021 Feb 10, 2022	BUY	$9.8 - $17.02 $808,480 - $1.4 Million	82,498 New	82,498 $1.35 Million

5.23M

Ticker PRDS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,320,900
Description
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.